Back to Today's briefing
Business·Reuters - World (Google News)·8/2/2026, 11:58:01 PM·
AstraZeneca held talks with Bristol Myers Squibb on $400 billion megadeal, source says - Reuters
Pharmaceutical giants AstraZeneca and Bristol Myers Squibb reportedly discussed a potential merger valued at approximately $400 billion, according to a source familiar with the matter. If completed, the deal would represent one of the largest consolidations in the pharmaceutical industry's history.
AI-generated summary. Social Pulse does not publish the full article. This brief is a neutral paraphrase by AI. Read the original at Reuters - World (Google News) using the link below.
Related briefs
- Reuters - World (Google News)Japan confirms joint FX intervention with U.S., says won't hesitate for more - Reuters
Guardian - WorldBP to sell North Sea business; AI companies lead record surge on Korea’s stock market – business live- Reuters - World (Google News)Japan conducts massive yen-buying intervention, Nikkei reports - Reuters
- Reuters - World (Google News)South Korea curbs may not save investors slaughtered by $2 trillion rout - Reuters
- Reuters - World (Google News)South Korea $2 trillion stock rout breaks records as SK Hynix results disappoint - Reuters
- Google News - War & ConflictTrump’s 50% Tariffs on Canada Risk Igniting a Fresh Trade War - WTTW
COMMENTS · 0
Join the conversation
Be the first to comment.